Molecure S.A. (MOC.WA)

PLN 10.0

(-1.96%)

Total Assets Summary of Molecure S.A.

Molecure S.A.'s latest annual total assets in 2023 was 168.57 Million PLN , up 22.1% from previous year.
Molecure S.A.'s latest quarterly total assets in 2024 Q3 was 87.71 Million PLN , down -8.37% from previous quarter.
Molecure S.A. reported annual total assets of 138.06 Million PLN in 2022, down -8.93% from previous year.
Molecure S.A. reported annual total assets of 151.59 Million PLN in 2021, down -1.24% from previous year.
Molecure S.A. reported quarterly total assets of 95.72 Million PLN for 2024 Q2, down -12.01% from previous quarter.
Molecure S.A. reported quarterly total assets of 87.71 Million PLN for 2024 Q3, down -8.37% from previous quarter.

Annual Total Assets Chart of Molecure S.A. (2023 - 2014)

Historical Annual Total Assets of Molecure S.A. (2023 - 2014)

Year	Total Assets	Total Assets Growth
2023	168.57 Million PLN	22.1%
2022	138.06 Million PLN	-8.93%
2021	151.59 Million PLN	-1.24%
2020	153.49 Million PLN	79.14%
2019	85.68 Million PLN	-0.38%
2018	86.01 Million PLN	148.82%
2017	34.56 Million PLN	122.81%
2016	15.51 Million PLN	-6.09%
2015	16.52 Million PLN	263.6%
2014	4.54 Million PLN	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	108.78 Million PLN	-35.47%
2024 Q2	95.72 Million PLN	-12.01%
2024 Q3	87.71 Million PLN	-8.37%
2023 Q2	127.29 Million PLN	-3.8%
2023 Q3	175.44 Million PLN	37.83%
2023 Q4	168.57 Million PLN	-3.92%
2023 FY	168.57 Million PLN	22.1%
2023 Q1	132.31 Million PLN	-4.16%
2022 Q3	140.79 Million PLN	-1.06%
2022 Q2	142.3 Million PLN	-3.62%
2022 FY	138.06 Million PLN	-8.93%
2022 Q1	147.64 Million PLN	-2.6%
2022 Q4	138.06 Million PLN	-1.94%
2021 Q4	151.59 Million PLN	1.47%
2021 Q3	149.39 Million PLN	-2.06%
2021 Q2	152.53 Million PLN	-1.19%
2021 FY	151.59 Million PLN	-1.24%
2021 Q1	154.36 Million PLN	0.57%
2020 Q1	83.7 Million PLN	-2.32%
2020 Q2	84.1 Million PLN	0.48%
2020 FY	153.49 Million PLN	79.14%
2020 Q4	153.49 Million PLN	87.4%
2020 Q3	81.91 Million PLN	-2.61%
2019 Q4	85.68 Million PLN	0.66%
2019 FY	85.68 Million PLN	-0.38%
2019 Q3	85.12 Million PLN	-0.98%
2019 Q2	85.97 Million PLN	-1.1%
2019 Q1	86.92 Million PLN	1.06%
2018 Q4	86.01 Million PLN	2.02%
2018 FY	86.01 Million PLN	148.82%
2018 Q1	32.15 Million PLN	-6.97%
2018 Q2	87.16 Million PLN	171.05%
2018 Q3	84.31 Million PLN	-3.28%
2017 Q2	32.09 Million PLN	0.0%
2017 FY	34.56 Million PLN	122.81%
2017 Q3	32.53 Million PLN	1.37%
2017 Q4	34.56 Million PLN	6.24%
2017 Q1	- PLN	-100.0%
2016 Q4	15.51 Million PLN	0.0%
2016 FY	15.51 Million PLN	-6.09%
2016 Q1	- PLN	0.0%
2015 FY	16.52 Million PLN	263.6%
2014 FY	4.54 Million PLN	0.0%

Peer Total Assets Comparison of Molecure S.A.

Name	Total Assets	Total Assets Difference
Bioceltix S.A.	12.73 Million PLN	-1223.703%
BIOTON S.A.	822.22 Million PLN	79.497%
Captor Therapeutics Spolka Akcyjna	97.29 Million PLN	-73.266%
Mabion S.A.	208.25 Million PLN	19.052%
NanoGroup S.A.	8.63 Million PLN	-1853.03%
Pharmena S.A.	24.13 Million PLN	-598.564%
Poltreg S.A.	127.09 Million PLN	-32.636%
Pure Biologics Spólka Akcyjna	22.73 Million PLN	-641.391%
Ryvu Therapeutics S.A.	403.2 Million PLN	58.19%
Synthaverse S.A.	265.9 Million PLN	36.602%
Urteste S.A.	29.59 Million PLN	-469.557%